Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > NR

<< Previous

Bullboard Posts

Next >>

Comment by Smokey1958on Sep 12, 2024 8:24pm

111 Views

Post# 36221469

RE:RE:NR

What are you talking about? When those options were promoted in 2022 THRM, although they should have been, was not at the same stage it is now. Something definitely went sideways with AcuVid for which we will never get the story. Venowave alone presents a very different scenario for 2024, 2025 and beyond. For one, the device has already cleared all the major issues and was thoroughly tested ...in Canada.

So yes, I believe offering options at $.08 is definitely big news.

<< Previous

Bullboard Posts

Next >>

Rogers buys out Bell, becomes majority owner of MLSE and Maple Leafs